MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12020-022-03261-y

Медицинская библиотека · Endocrine · 2022

Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?

Chiloiro Sabrina, Giampietro Antonella, Gagliardi Irene, Bondanelli Marta, Epifani Valeria, Milardi Domenico, Ambrosio Maria Rosaria, Zatelli Maria Chiara, Pontecorvi Alfredo, De Marinis Laura, Bianchi Antonio

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Acromegaly is a rare but potentially life-threatening disease, if not promptly managed, for the systemic complications due to the GH/IGF-I hypersecretion. According to the increased population life span, the number of older acromegaly patients is growing. We aim to investigate clinical features of elderly acromegaly (elderly-ACRO) and to identify the risk factors for the occurrence of comorbidities in elderly-ACRO.

MATERIALS AND

METHODS

A retrospective and multi-center study was performed on acromegaly patients. Acromegaly comorbidities were compared among elderly-ACRO (>65 years), young acromegaly patients (young-ACRO if ≤65 years) and a control group of age and gender-matched subjects.

RESULT: Fifty of the 189 enrolled patients were elderly-ACRO (26.5%). Cardiovascular, metabolic, neurological/psychiatric and joint/articular disorders, nodular thyroid disease, sleep apnoea syndrome and skeletal fragility occurred more frequently in elderly-ACRO as compared to controls. Cardiovascular and metabolic disorders, nodular thyroid disease occurred significantly more frequently in elderly-ACRO as compared to young-ACRO and controls. On the other hand, neurological/psychiatric, joint/articular disorders and bone fragility occur with a similar frequency among elderly and young-ACRO. We found that elderly-ACRO had an increased risk for the occurrence of systemic arterial hypertension (p < 0.001, OR: 5.4 95%IC:2.6-10.9), left ventricular hypertrophy (p = 0.01, OR: 3 95%IC: 1.5-5.8) and metabolic disorders (p = 0.006, OR: 4.1 95%IC: 2-8.3).

CONCLUSION

Our results may suggest that some acromegaly comorbidities may be predominantly due to acromegaly "per-se" rather than to aging. On the contrary, cardiovascular and metabolic disorders seem to be due to aging as well.

Для цитирования: Chiloiro Sabrina, Giampietro Antonella, Gagliardi Irene, Bondanelli Marta, Epifani Valeria, Milardi Domenico, Ambrosio Maria Rosaria, Zatelli Maria Chiara, Pontecorvi Alfredo, De Marinis Laura, Bianchi Antonio. Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients?. Endocrine. 2022. DOI: 10.1007/s12020-022-03261-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.